 | Up a level |
Ferreri, Andreas J M; Illerhaus, Gerald; Doorduijn, Jeanette K; Auer, Dorothee P; Bromberg, Jacoline E C; Calimeri, Teresa; Cwynarski, Kate; Fox, Christopher P; Hoang-Xuan, Khê; Malaise, Denis; Ponzoni, Maurilio; Schorb, Elisabeth; Soussain, Carole; Specht, Lena; Zucca, Emanuele; Buske, Christian; Jerkeman, Mats; Dreyling, Martin (2024). Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. HemaSphere, 8(6) Wolters Kluwer Health 10.1002/hem3.89
Dreyling, Martin; Doorduijn, Jeanette; Giné, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke; Shpilberg, Ofer; Gomes da Silva, Maria; Leppä, Sirpa; Jiang, Linmiao; Stilgenbauer, Stephan; Kerkhoff, Andrea; Jachimowicz, Ron D; Celli, Melania; Hess, Georg; Arcaini, Luca; ... (2024). Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network. The lancet, 403(10441), pp. 2293-2306. Elsevier 10.1016/S0140-6736(24)00184-3
Novak, Urban; Fehr, Martin; Schär, Sämi; Dreyling, Martin; Schmidt, Christian; Derenzini, Enrico; Zander, Thilo; Hess, Georg; Mey, Ulrich; Ferrero, Simone; Mach, Nicolas; Boccomini, Carola; Böttcher, Sebastian; Voegeli, Michèle; Cairoli, Anne; Ivanova, Vanesa-Sindi; Menter, Thomas; Dirnhofer, Stefan; Scheibe, Bernhard; Gadient, Sandra; ... (2023). Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13). EClinicalMedicine, 64, p. 102221. Elsevier 10.1016/j.eclinm.2023.102221
Vidal, Liat; Gafter-Gvili, Anat; Leibovici, Leonard; Dreyling, Martin; Ghielmini, Michele; Hsu Schmitz, Shu-Fang; Cohen, Amos; Shpilberg, Ofer (2009). Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized Trials. Journal of the National Cancer Institute JNCI, 101(4), pp. 248-255. Cary, N.C.: Oxford University Press 10.1093/jnci/djn478
